Tamoxifen Completed Phase 2 Trials for Estrogen Receptor Positive Breast Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02988986TAK-228 Plus Tamoxifen in Patients With ER-Positive, HER2-negative Breast Cancer